Article citationsMore>>

Harper, D., Gall, S., Naud, P., Quint, W., Dubin, G., Jenkins, D., et al. (2008) Sustained Immunogenicity and High Efficacy against HPV 16/18 Related Cervical Neoplasia: Long-Term Follow Up through 6.4 Years in Women Vaccinated with Cervarix (GSK’s HPV-16/18 AS04 Candidate Vaccine). Gynecologic Oncology, 109, 158-159.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top